Results 151 to 160 of about 67,666 (216)

Oncologic Outcomes After ABO-Incompatible Versus Compatible Living Donor Liver Transplantation for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Kim SH, An BH, Lee JA, Jeong GW.
europepmc   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

Delayed Hypersensitivity Reaction to Insulin: A Case Report. [PDF]

Cureus
Aharmim M, Lakhal M, Reguig N, El Bourkadi JE.   +3 more
europepmc   +1 more source

The potential for biased signalling in the P2Y receptor family of GPCRs

British Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk, Simon Pitchford, Graham Ladds   +2 more
wiley   +1 more source

Administration of Intravenous Ferric Carboxymaltose in a Patient With Iron-Deficiency Anemia and Allergy to 2 Oral Iron Preparations. [PDF]

J Pediatr Pharmacol Ther
Wallace J, Trabal A.
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Long-term renal function and complication profiles after ABO-incompatible <i>vs</i> compatible living-donor kidney transplantation: A single-center experience. [PDF]

World J Transplant
Braga BG, Cunha A, Almeida M, Sousa S, Trigo AF, Inácio A, Dias B, Silvano J, Ribeiro C, Pedroso S, Sampaio M, Bini-Antunes M, Martins S.   +12 more
europepmc   +1 more source

Biomarkers Predicting Sustained Unresponsiveness After Oral Immunotherapy in the OPIA Trial

Allergy, EarlyView.
Duan Ni, Gabriela Pinget, Brigitte Santner‐Nanan, Catherine L. Lai, Laurence Macia, Dianne E. Campbell, Peter Hsu, Ralph Nanan   +7 more
wiley   +1 more source

Cannabigerol reverses mechanical allodynia through α2A‐adrenergic modulation of thalamocortical signaling in chemotherapy‐induced neuropathy

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Chemotherapy‐induced peripheral neuropathy (CIPN) is a prevalent and treatment‐resistant side effect of platinum‐based chemotherapy, characterised by mechanical allodynia. Cannabigerol (CBG), a non‐psychoactive cannabinoid, has shown antinociceptive potential, but its site and mechanism of action remain unclear.
Quinn W. Wade, Nathan Morris, Diana E. Sepulveda, Alonso Cortez‐Resendiz, Christopher Brandl, Jennifer E. Lausch, Mariya Starostina, Nicholas M. Graziane   +7 more
wiley   +1 more source

Comparison of rapid and same-day desensitization protocols in hypersensitivity reactions to platinum and taxanes: a retrospective cohort study. [PDF]

Front Allergy
Torres Górriz MC, Borrás Cuartero J, Viedma Ayllón P, Sánchez Hernández A, Vergara Hernández C, Gil Viciano I, Enrique E.   +6 more
europepmc   +1 more source